News

Pfizer announced positive top-line results of a Phase 3 study examining the use of LYRICA (pregabalin) Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric…
Read More...

TEDOR Pharma announced the closing of a recapitalization and reorganization of its business, funded by investments from DORA Ventures, Inc. DORA Ventures is a newly formed investment…
Read More...

Catalent Pharma Solutions and Valerius Biopharma AG announced that they are to collaborate on the development and manufacture of Valerius’ biosimilar products. Under the agreement,…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. Aimovig is a novel therapeutic…
Read More...

Amneal Pharmaceuticals announced it has received final U.S. Food and Drug Administration (FDA) approval on its Abbreviated New Drug Application for a generic version of Welchol…
Read More...

Albireo Pharma announced the first patient has been enrolled in PEDFIC-1, a Phase 3 clinical trial of lead product candidate A4250, an ileal bile acid transporter (IBAT) inhibitor being…
Read More...

BioLamina and collaborators have partnered with Novo Nordisk A/S (Novo Nordisk), a Danish multinational pharmaceutical company, allowing Novo Nordisk to develop novel stem cell based…
Read More...

Emulate, Inc. has formed a collaborative partnership with AstraZeneca’s Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-Chips technology within the…
Read More...

The National Institutes of Health is supporting efforts to broaden biomedical scientists’ access to cryo-electron microscopy (cryo-EM), the Nobel Prize-winning (link is external)…
Read More...

The U.S. Food and Drug Administration approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney…
Read More...

Eli Lilly and Company announced that galcanezumab met its primary endpoint in a Phase 3 study of patients with episodic cluster headache, demonstrating statistically significant…
Read More...

Cambrex Corporation announced that it has completed a pilot plant expansion at its High Point, NC facility with the installation and commissioning of a fourth reactor suite, increasing…
Read More...

UCB announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the company’s newest anti-epileptic drug (AED) BRIVIACT …
Read More...

Zymeworks Inc. and Daiichi Sankyo announced that they entered into a new license agreement, building upon their 2016 cross-licensing and collaboration agreement. “With a successful…
Read More...

Eli Lilly and Company announced an agreement to acquire AurKa Pharma, Inc., a company established by TVM Capital Life Science to develop oncology compound AK-01, an Aurora kinase A…
Read More...

Medigene AG announced the significant expansion of its successful strategic alliance with bluebird bio, a leader in gene and cell therapies, focusing on the research and development of…
Read More...

Quality Packaging Specialists Int'l (QPSI) and Supply Chain Wizard announced their newly formed partnership, supporting QPSI's mission to digitally refine their US-based factory network…
Read More...

FUJIFILM Holdings Corporation (President: Kenji Sukeno) announced it plans to merge TOYAMA CHEMICAL CO., LTD., a company that conducts the research, development, manufacture, and sales…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with…
Read More...

The U.S. Food and Drug Administration, in two complaints filed in federal court, is seeking permanent injunctions to stop two stem cell clinics from marketing stem cell products without…
Read More...